| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |